Adult presentation of subacute necrotizing encephalomyelopathy in two siblings by Khandwala, Kumail & Mubarak, Fatima
eCommons@AKU 
Department of Radiology Medical College, Pakistan 
8-2019 
Adult presentation of subacute necrotizing encephalomyelopathy 
in two siblings 
Kumail Khandwala 
Fatima Mubarak 
Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_radiol 
Received 07/29/2019 
Review began 08/07/2019 
Review ended 08/27/2019 
Published 08/29/2019
© Copyright 2019
Khandwala et al. This is an open
access article distributed under the
terms of the Creative Commons
Attribution License CC-BY 3.0., which
permits unrestricted use, distribution,
and reproduction in any medium,
provided the original author and
source are credited.
Adult Presentation of Subacute Necrotizing
Encephalomyelopathy in Two Siblings
Kumail Khandwala  , Fatima Mubarak 
1. Radiology, Aga Khan University Hospital, Karachi, PAK 2. Radiology, The Aga Khan University,
Karachi, PAK
 Corresponding author: Fatima Mubarak, fatima.mubarak@aku.edu 
Disclosures can be found in Additional Information at the end of the article
Abstract
Subacute necrotizing encephalomyelopathy (SNE) or Leigh syndrome is a rare progressive
neurodegenerative mitochondrial disorder typically manifesting in the pediatric age group with
variable clinical presentation and genetic heterogeneity. Late-onset varieties are extremely rare
and only few cases have been reported globally. Neuroimaging however shows characteristic
symmetrical necrotic lesions in the basal ganglia and/or brainstem. We report cases of two
siblings who had history of seizures, but presented to us in adulthood. They had similar clinical
presentation and radiological features on magnetic resonance imaging (MRI) and were
subsequently diagnosed with SNE primarily based on imaging.
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Introduction
Leigh syndrome, also termed subacute necrotizing encephalomyelopathy (SNE) and first
described by Denis Leigh in 1951, is a rare, inherited progressive neurodegenerative disorder
that usually manifests in infancy or early childhood [1]. Usual age of presentation is before six
months of age in about 50% cases. Late-onset and adult-onset varieties of Leigh syndrome have
been rarely described in the literature [2-4]. We report an atypical variety of SNE that presented
in adulthood in two siblings who had identical clinical presentation and magnetic resonance
imaging (MRI) features.
Case Presentation
An 18-year-old male presented to the emergency room (ER) with complaints of recurrent
episodes of seizures for the past one week. He had a history of generalized tonic clonic seizures
for the last four years and was the product of second-degree consanguineous marriage, with an
uneventful perinatal history or past medical history. On initial examination, he was
unconscious with Glasgow Coma Scale (GCS) of 5 and afebrile. Initial management aimed at
controlling the seizures with Diazepam. His pulse was 154 beats per minute, respiratory rate 36
per minute and blood pressure 84/46 mm Hg. Central nervous system (CNS) examination
showed increased tone in the lower limbs. Deep tendon reflexes were exaggerated with positive
bilateral Babinski sign. Pupils were dilated and sluggishly reacting to light. Fundus examination
and visual evoked potentials were normal. The above clinical findings were highly suggestive of
a neurodegenerative disorder and the patient was further investigated in which cerebrospinal
fluid (CSF) lactate was 3.9 mmol/L (normal <3 mmol/L) and serum lactate was 1.6 mmol/L
(normal 0.5-1 mmol/L) and were found to be mildly elevated. CSF, blood and urine cultures
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were negative. Herpes simplex virus (HSV) by polymerase chain reaction (PCR) was negative.
Mycobacterium tuberculosis (MTB) by PCR was negative. Ceruloplasmin levels of 0.29 g/L
(normal 0.2-0.6 g/L) ruled out Wilson's disease. Initial electroencephalogram (EEG) showed
reactive theta and delta slowing.
MRI showed symmetrical abnormal signals in cortical grey matter, bilateral caudate nuclei,
bilateral putamen, bilateral thalami and bilateral cerebellar hemispheres appearing
predominantly hyperintense on T2-weighted and FLAIR images with diffusion restriction
(Figure 1).
FIGURE 1: Magnetic Resonance Imaging
(A & B) Axial T2-weighted images showing symmetrical abnormal T2 hyperintense signals in
cortical grey matter, bilateral caudate nuclei, bilateral putamen, bilateral thalami and bilateral
cerebellar hemispheres (white arrows).
(C & D) Diffusion-weighted sequences and apparent diffusion coefficient maps demonstrating
positive diffusion restriction in these affected areas.
MR spectroscopy was also done which showed inverted doublet lactate peak (Figure 2). He was
managed on the lines of a suspected mitochondrial disorder and started on Co-enzyme Q-10
and L-carnitine. He was also started on Levetiracetam for symptomatic relief and was asked to
follow up in the neurology clinic; however, he was subsequently lost to follow-up.
FIGURE 2: Magnetic Resonance Spectroscopy
Spectroscopy done in the region of caudate nucleus and cortical matter shows inverted doublet
lactate peak at 1.3 ppm.
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A few years later, his sister, a 20-year-old female, was brought to the ER with seizures and
altered mentation. She also had recurrent epilepsy for five years. It was discovered on history
taking that her brother who had lost to follow-up previously, died two years ago from his
neurodegenerative disorder. Her GCS at the time of admission was 5/15 with hyper-reflexia,
positive Babinski’s sign. Her laboratory workup showed increased creatine phosphokinase levels
of 969 IU/L (normal 34-145 IU/L). CSF detailed report and culture was unremarkable. Her EEG
also showed diffuse delta and theta slowing (Figure 3).
FIGURE 3: Electroencephalogram
Electroencephalogram showing diffuse delta and theta wave slowing.
Urine toxicology showed no evidence of amphetamines, cannabinoids, or opiates. MRI was done
which showed similar hyperintense lesions in cortical and deep grey matter along with
involvement of the periaqueductal grey matter. Diffusion restriction was present as well
(Figure 4). She was also started on Levetiracetam for seizures and L-carnitine for symptomatic
treatment. In view of the guarded prognosis, the family subsequently moved the patient to
another facility due to financial constraints. Based on the clinical presentation and MRI
features, a diagnosis of subacute necrotizing encephalomyelopathy (Leigh’s syndrome) was
established in these two siblings.
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FIGURE 4: Magnetic Resonance Imaging
(A) Axial T2-weighted image showing similar symmetrical T2 hyperintense lesions in cortical and
deep grey matter (white arrows).
(B) Axial T2-weighted image showing involvement of the periaqueductal grey (white arrow).
(C) Coronal FLAIR image showing that the lesions were hyperintense on FLAIR.
(D & E) Diffusion-weighted sequences and apparent diffusion coefficient maps showing patchy
diffusion restriction in the affected regions.
Discussion
Subacute necrotizing encephalomyelopathy is a rare, inherited progressive neurodegenerative
disorder that usually manifests in infancy or early childhood [1]. Clinical presentation of SNE is
variable. In most usual cases that present in infancy or childhood there is psychomotor delay or
regression, brainstem and pyramidal signs. Dysfunction of the respiratory chain enzymes is
responsible for the disease. Some cases display a maternal inheritance, others follow an
autosomal recessive (pyruvate carboxylase, SURF1 gene mutations with cytochrome C oxidase
(COX) deficiency, adenosine triphosphate [ATP] synthase subunit 6 and complex I deficiencies)
or sex-linked (pyruvate dehydrogenase E1 gene mutations) pattern of inheritance. In some
cases, the genetic cause remains unknown [5].
Despite this, the neuroimaging and pathological features of affected children are identical.
Characteristic focal, bilateral, and symmetric necrotic lesions associated with demyelination are
noted in the brainstem, diencephalon, basal ganglia, and cerebellum. A diagnosis of SNE can be
made without histopathology on the basis of clinical signs and symptoms, mode of inheritance,
metabolic abnormalities such as elevated CSF lactate, and neuroimaging findings [6,7]. In some
reported cases, the diagnosis was purely made on clinical presentation and MRI findings
[8,9]. Adult-onset SNE is rare, and has previously been defined as patients who survived longer
than 18 years [4]. In addition, the clinical manifestations may also be different than those of
children with less incidence of developmental delay as seen in our cases. Previously reported
cases have excluded infections, autoimmune diseases and toxins as have we in our cases [10].
Seizures are a less common clinical presentation of this disease, however, in a recent study,
clinical seizures were observed in 56% of patients with SNE. All their patients were found to
have slow and disorganized background neural activity on EEG as observed in both of our cases
[11].
Genetic testing, histopathology or molecular studies were not performed in our patients due
to financial constraints. However, with appropriate investigations, accurate diagnosis and
prompt institution of adequate supportive therapy such as with thiamine (vitamin B1), biotin
(vitamin B7), succinic acid and Coenzyme Q10, symptomatic amelioration can be achieved in
some cases, thereby adding life to the limited years of survival in affected patients [12].
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Conclusions
The diagnosis of subacute necrotizing encephalomyelopathy should be considered in
appropriate clinical and laboratory settings whenever symmetrical abnormalities are
encountered on imaging predominantly in the basal ganglia and/or brainstem. However, the
adult-onset variety is extremely rare and requires a high index of suspicion for diagnosis.
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